BRPI0514867A - forma polimórfica de inulina e uso dos mesmos - Google Patents

forma polimórfica de inulina e uso dos mesmos

Info

Publication number
BRPI0514867A
BRPI0514867A BRPI0514867-7A BRPI0514867A BRPI0514867A BR PI0514867 A BRPI0514867 A BR PI0514867A BR PI0514867 A BRPI0514867 A BR PI0514867A BR PI0514867 A BRPI0514867 A BR PI0514867A
Authority
BR
Brazil
Prior art keywords
inulin
din
polymorphic form
compositions
gin
Prior art date
Application number
BRPI0514867-7A
Other languages
English (en)
Inventor
Peter D Cooper
Nikolai Petrovsky
Original Assignee
Vaxine Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2004905032A external-priority patent/AU2004905032A0/en
Application filed by Vaxine Pty Ltd filed Critical Vaxine Pty Ltd
Publication of BRPI0514867A publication Critical patent/BRPI0514867A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/733—Fructosans, e.g. inulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0051—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Fructofuranans, e.g. beta-2,6-D-fructofuranan, i.e. levan; Derivatives thereof
    • C08B37/0054—Inulin, i.e. beta-2,1-D-fructofuranan; Derivatives thereof

Abstract

FORMA POLIMóRFICA DE INULINA E USOS DOS MESMOS A presente invenção refere-se a uma nova forma polimórfica de inulina, designada deita inulina (dIN), a processos para a preparação de dIN, composições compreendendo dIN e seus usos. A presente invenção também refere-se ao uso de dIN e composições compreendendo dIN na preparação de gama inulina (gIN), composições compreendendo gIN e seus usos.
BRPI0514867-7A 2004-09-02 2005-09-01 forma polimórfica de inulina e uso dos mesmos BRPI0514867A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2004905032A AU2004905032A0 (en) 2004-09-02 New polymorphic form of particulate inulin
PCT/AU2005/001328 WO2006024100A1 (en) 2004-09-02 2005-09-01 New polymorphic form of inulin and uses thereof

Publications (1)

Publication Number Publication Date
BRPI0514867A true BRPI0514867A (pt) 2008-06-24

Family

ID=35999639

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0514867-7A BRPI0514867A (pt) 2004-09-02 2005-09-01 forma polimórfica de inulina e uso dos mesmos

Country Status (6)

Country Link
US (1) US9492547B2 (pt)
EP (1) EP1791873B1 (pt)
JP (1) JP5529377B2 (pt)
BR (1) BRPI0514867A (pt)
CA (1) CA2577702C (pt)
WO (1) WO2006024100A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10150819B2 (en) 2008-04-23 2018-12-11 Tiense Suikerraffinaderij N.V. Aqueous dispersion of fructan-containing particles, method of preparation and use
JP2013505302A (ja) * 2009-09-18 2013-02-14 ヴァクシン プロプライエトリー リミテッド イヌリンの新たな多形形態エプシロン・イヌリンおよびその組成物
BR112013032675A2 (pt) * 2011-06-19 2017-08-08 Vaxine Pty Ltd composição adjuvante de vacina compreendendo partículas de inulina
BR112014017923B1 (pt) * 2012-01-20 2022-12-13 South Dakota State University Método para a produção de uma composição
DE102014012717A1 (de) * 2014-08-27 2016-03-03 Johnson & Johnson Medical Gmbh Chirurgisches Implantat
US20190325991A1 (en) 2016-12-28 2019-10-24 National Institutes Of Biomedical Innovation, Health And Nutrition Characteristic analysis method and classification of pharmaceutical components by using transcriptomes
US11090380B2 (en) 2018-06-04 2021-08-17 Applied Biotechnology Institute, Inc. Methods and compositions to increase immune response to vaccines

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4954622A (en) * 1985-10-31 1990-09-04 The Australian National University Pharmaceutical composition and method containing gamma inulin or derivative thereof
US5422346A (en) * 1988-01-06 1995-06-06 California Natural Products Instant dried dahlia inulin juice and its method of production and usage
CA1337047C (en) * 1988-08-18 1995-09-19 Peter Dodd Cooper Gamma inulin compositions
EP0769026B2 (en) * 1994-07-07 2005-02-16 Tiense Suikerraffinaderij N.V. (Raffinerie Tirlemontoise S.A.) Fractionated polydisperse compositions
US5840884A (en) * 1996-03-01 1998-11-24 Kraft Foods, Inc. Method for controlling crystal morphology of inulin

Also Published As

Publication number Publication date
JP2008511693A (ja) 2008-04-17
EP1791873A1 (en) 2007-06-06
CA2577702C (en) 2014-02-11
JP5529377B2 (ja) 2014-06-25
US20090029940A1 (en) 2009-01-29
US9492547B2 (en) 2016-11-15
EP1791873A4 (en) 2011-09-07
EP1791873B1 (en) 2014-04-02
CA2577702A1 (en) 2006-03-09
WO2006024100A1 (en) 2006-03-09

Similar Documents

Publication Publication Date Title
BRPI0514867A (pt) forma polimórfica de inulina e uso dos mesmos
TW200740799A (en) Alpha2C adrenoreceptor agonists
EA200970581A1 (ru) Кристаллическое твёрдое основание разагилина
CL2008001839A1 (es) Compuestos derivados de 2,7-diazaespirociclos, inhibidores de 11-beta hidroxil esteroide deshidrogenasa tipo 1; composicion farmaceutica que comprende a dichos compuestos; utiles para tratar la obesidad, diabetes, intolerancia a la glucosa, diabetes tipo ii, entre otras enfermedades.
TW200621313A (en) Pharmaceutical compositions
BRPI0510273A (pt) derivados de tetraazabenzo[e]azuleno e análogos destes
TW200716584A (en) Dihydrobenzofuran derivatives and uses thereof
TW200700092A (en) Tigecycline compositions and methods of preparation
TNSN07360A1 (en) Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof
CU20060038A7 (es) Forma cristalina gamma-d del clorhidrato de la ivabradina, su procedimiento de preparación y las composiciones farmacéuticas que las contienen
CU20060037A7 (es) Forma cristalina gamma del clorhidrato de la ivabradina, su procedimiento de preparación y las composiciones farmacéuticas que las contienen
MX2007008790A (es) Pirazolo piridinas sustituidas, composiciones que las contienen, metodo de produccion de las mismas, y su uso.
BRPI0500393B8 (pt) forma cristalina ii de agomelatina e sua composição farmacêutica
GT200600520A (es) Agentes antibacterianos
UA98804C2 (ru) Катехоламиновые производные и фармацевтическая композиция на их основе
TW200745122A (en) New compounds I
DE602006017724D1 (de) Salicylsäurederivate
EA200701172A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение
JO2747B1 (en) Vehicles
MX2007006042A (es) Bengamidas que poseen un ciclo caprolactama sustituido, procedimiento de preparacion, composiciones que las contienen y utilizacion.
BRPI0512392A (pt) composições contendo aequorina e uso da aequorina
WO2012127067A3 (en) Hydraulic binder composition
EA200602049A1 (ru) Пролекарства стероидов с андрогенным действием
TW200613315A (en) Estradiol prodrugs
NO20074528L (no) Substituerte pyrroler, sammensetninger, fremgangsmate for fremstilling og anvendelse av samme

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B07D Technical examination (opinion) related to article 229 of industrial property law
B08F Application fees: dismissal - article 86 of industrial property law
B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)